Larson Financial Group’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$121K Buy
569
+56
+11% +$11K ﹤0.01% 1082
2026
Q1
$101K Buy
513
+58
+13% +$11.3K ﹤0.01% 996
2025
Q4
$79K Buy
455
+117
+35% +$21.3K ﹤0.01% 1020
2025
Q3
$64.4K Sell
338
-135
-29% -$24K ﹤0.01% 1051
2025
Q2
$85K Buy
473
+150
+46% +$26.1K ﹤0.01% 903
2025
Q1
$54.7K Buy
323
+163
+102% +$26.8K ﹤0.01% 991
2024
Q4
$24.1K Sell
160
-70
-30% -$10.9K ﹤0.01% 1147
2024
Q3
$35.8K Buy
230
+1
+0.4% +$149 ﹤0.01% 1012
2024
Q2
$31.4K Buy
229
+100
+78% +$13.7K ﹤0.01% 926
2024
Q1
$17.2K Sell
129
-40
-24% -$5.19K ﹤0.01% 920
2023
Q4
$23.3K Hold
169
﹤0.01% 816
2023
Q3
$20.6K Hold
169
﹤0.01% 808
2023
Q2
$23.7K Hold
169
﹤0.01% 695
2023
Q1
$23.8K Buy
169
+1
+0.6% +$143 ﹤0.01% 698
2022
Q4
$26.3K Hold
168
﹤0.01% 635
2022
Q3
$21K Sell
168
-179
-52% -$23.6K ﹤0.01% 623
2022
Q2
$46K Buy
347
+318
+1,097% +$43.3K 0.01% 386
2022
Q1
$4K Hold
29
﹤0.01% 814
2021
Q4
$5K Hold
29
﹤0.01% 802
2021
Q3
$4K Hold
29
﹤0.01% 715
2021
Q2
$4K Buy
29
+1
+4% +$131 ﹤0.01% 648
2021
Q1
$4K Hold
28
﹤0.01% 645
2020
Q4
$3K Hold
28
﹤0.01% 598
2020
Q3
$3K Hold
28
﹤0.01% 562
2020
Q2
$3K Buy
+28
New +$2.97K ﹤0.01% 522

Other funds holding DGX

Larson Financial Group's DGX Position: Q2 2026 in Review

Larson Financial Group increased its Quest Diagnostics (DGX) stake by 11% in Q2 2026, buying an estimated $11K and bringing the position to 569 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #1082.

Larson Financial Group first reported a position in DGX in Q2 2020 and has held it in 25 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Larson Financial Group held 569 shares of Quest Diagnostics worth $121K as of Q2 2026.
  • Larson Financial Group bought 56 Quest Diagnostics shares in Q2 2026, an estimated $11K.
  • Quest Diagnostics made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #1082 holding.
  • Larson Financial Group first reported a position in Quest Diagnostics in Q2 2020 and has held it in 25 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.